UPL (512070) Aktienübersicht
UPL Limited bietet zusammen mit seinen Tochtergesellschaften Produkte und Lösungen für eine nachhaltige Landwirtschaft in Indien, Europa, Nordamerika, Lateinamerika und auf internationaler Ebene an. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 4/6 |
| Finanzielle Gesundheit | 5/6 |
| Dividenden | 4/6 |
512070 Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
UPL Limited Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | ₹599.30 |
| 52-Wochen-Hoch | ₹812.00 |
| 52-Wochen-Tief | ₹565.25 |
| Beta | 0.52 |
| 1 Monat Veränderung | -8.10% |
| 3 Monate Veränderung | -4.17% |
| 1 Jahr Veränderung | -7.89% |
| 3 Jahre Veränderung | -11.93% |
| 5 Jahre Veränderung | -24.39% |
| Veränderung seit IPO | 1,519.72% |
Aktuelle Nachrichten und Updates
Narrativ-Update • Jun 16
512070: Upcoming Board Decisions And Investor Day Will Support Stronger Outlook
Analysts have trimmed their price target on UPL to ₹890 from ₹947, citing updated assumptions that combine slightly adjusted revenue growth expectations with a lower discount rate, a reduced profit margin outlook, and a higher future P/E multiple. What's in the News for UPL UPL has scheduled a board meeting on May 11, 2026, at 11:15 Indian Standard Time to consider, approve, and record the audited consolidated and standalone financial results for the year ended March 31, 2026.
Narrativ-Update • Jun 02
512070: Upcoming Governance Meetings Will Support Stronger Medium Term Re-Rating
Analysts have trimmed their fair value estimate for UPL slightly from ₹776.22 to ₹767.00, as modest adjustments to the discount rate and forward P/E assumptions offset essentially unchanged revenue growth and profit margin expectations. What's in the News Board meeting scheduled for May 11, 2026, at 11:15 IST to consider and approve audited consolidated and standalone financial results for the year ended March 31, 2026, and to consider recommending a dividend, if any (source: company board meeting notice).Narrativ-Update • May 18
512070: Upcoming Governance Meetings Will Support Stronger Medium Term Outlook
Analysts have trimmed their price target on UPL from ₹811.50 to ₹776.22, citing revised assumptions around profit margins, a higher future P/E multiple, and updated views on discount rates and revenue growth. What's in the News UPL has scheduled an Analyst/Investor Day, providing an opportunity to hear directly from management about the business and capital allocation plans.
Narrativ-Update • May 01
512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans
Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).Recent updates
Narrativ-Update • Jun 16
512070: Upcoming Board Decisions And Investor Day Will Support Stronger Outlook
Analysts have trimmed their price target on UPL to ₹890 from ₹947, citing updated assumptions that combine slightly adjusted revenue growth expectations with a lower discount rate, a reduced profit margin outlook, and a higher future P/E multiple. What's in the News for UPL UPL has scheduled a board meeting on May 11, 2026, at 11:15 Indian Standard Time to consider, approve, and record the audited consolidated and standalone financial results for the year ended March 31, 2026.Narrativ-Update • Jun 02
512070: Upcoming Governance Meetings Will Support Stronger Medium Term Re-Rating
Analysts have trimmed their fair value estimate for UPL slightly from ₹776.22 to ₹767.00, as modest adjustments to the discount rate and forward P/E assumptions offset essentially unchanged revenue growth and profit margin expectations. What's in the News Board meeting scheduled for May 11, 2026, at 11:15 IST to consider and approve audited consolidated and standalone financial results for the year ended March 31, 2026, and to consider recommending a dividend, if any (source: company board meeting notice).Narrativ-Update • May 18
512070: Upcoming Governance Meetings Will Support Stronger Medium Term Outlook
Analysts have trimmed their price target on UPL from ₹811.50 to ₹776.22, citing revised assumptions around profit margins, a higher future P/E multiple, and updated views on discount rates and revenue growth. What's in the News UPL has scheduled an Analyst/Investor Day, providing an opportunity to hear directly from management about the business and capital allocation plans.Narrativ-Update • May 01
512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans
Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).Narrativ-Update • Apr 17
512070: Composite Scheme And Governance Steps Will Support Stronger Medium Term Outlook
Analysts have trimmed their price target on UPL slightly from about ₹820.53 to ₹811.50, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiple. What's in the News Board meeting on Feb 20, 2026 to consider a Composite Scheme of Arrangement among UPL Limited and multiple group entities under Sections 230 to 232 and 234 of the Companies Act, 2013, based on recommendations from the Audit Committee and the Committee of Independent Directors (company filing).Narrativ-Update • Apr 03
512070: Upcoming Governance Decisions And Treasury Scheme Will Support A Stronger Outlook
Analysts have trimmed their price target on UPL from ₹975 to ₹947, citing updated assumptions on long term profit margins and P/E multiples, along with refreshed views on growth, discount rates and fair value. What's in the News UPL has called a Special or Extraordinary Shareholders Meeting for March 31, 2026, at 15:30 IST to seek approval for material related party transactions involving sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).Narrativ-Update • Mar 19
512070: Fair Pricing Will Rely On Execution Of Upcoming Restructuring Steps
Analysts have nudged their price target on UPL slightly higher to about ₹648 from roughly ₹641, citing updated assumptions around revenue growth, profit margins, a modestly lower discount rate, and a small adjustment to the expected future P/E multiple. What's in the News UPL has scheduled a board meeting on Feb 02, 2026 at 12:45 Indian Standard Time to consider and approve unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025, along with limited review reports from the statutory auditors (Key Developments).Narrativ-Update • Mar 05
512070: Composite Scheme Board Meeting Will Support Stronger Medium Term Outlook
Analysts have raised their price target on UPL by about ₹39 to ₹820, citing updated assumptions that reflect a slightly lower discount rate, a modest tweak to revenue growth and P/E expectations, and a higher projected profit margin. What's in the News Board meeting scheduled for Feb 20, 2026 at 14:30 IST to consider a Composite Scheme of Arrangement involving UPL and its subsidiaries UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited under Sections 230 to 232 and 234 of the Companies Act, 2013 (company filing).Narrativ-Update • Feb 18
512070: Revised Margins And Lower P/E Will Likely Struggle To Support Pricing
Analysts have raised their fair value estimate for UPL from ₹600.67 to ₹641.03, citing updated views on the discount rate, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).Narrativ-Update • Feb 04
512070: Higher Margin Assumptions And Upcoming Results Will Support A Stronger Fair Value Outlook
Analysts have raised their fair value estimate for UPL from ₹944 to ₹975, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News UPL has scheduled a board meeting on Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results.Narrativ-Update • Jan 21
512070: Higher Revenue And Margin Assumptions Will Support A Stronger Fair Value Outlook
Analysts have raised their fair value estimate for UPL from ₹911.93 to ₹944.00 after updating their assumptions for revenue growth, profit margins, discount rate and future P/E. What's in the News UPL has scheduled a Board Meeting on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Reports from the statutory auditors (company filing).Narrativ-Update • Jan 07
512070: Small Assumption Tweaks Will Likely Fail To Prevent Margin Pressure
Analysts have slightly increased their fair value estimate for UPL from ₹596.98 to ₹600.67. This reflects small adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E multiples.Narrativ-Update • Dec 19
512070: Future Margins Will Likely Deteriorate Despite Higher Market Expectations
Analysts have raised their price target for UPL from approximately 526.51 to 596.98, citing slightly stronger expectations for revenue growth and future valuation multiples, partly offset by a more conservative view on profit margins and discount rates. What's in the News UPL Limited has scheduled a board meeting for November 06, 2025 to consider and approve unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the limited review reports from the statutory auditors (company filing).Narrativ-Update • Dec 05
512070: Board Meeting And Stable Assumptions Will Shape Medium Term Outlook
Analysts have modestly raised their price target for UPL to ₹781.39, reflecting slightly improved discount rate and future P E assumptions, while largely maintaining their views on growth and profitability. What's in the News A board meeting is scheduled on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Statutory Auditors' limited review reports (company filing).Narrativ-Update • Nov 21
512070: Board Meetings And Adjusted Forecasts Will Influence Medium-Term Outlook
Analysts have raised their price target for UPL from $756.34 to $781.39. This reflects optimism driven by slightly improved revenue growth expectations and adjustments to projected profit margins and valuation multiples.Narrativ-Update • Nov 07
512070: Upcoming Board Decisions And Steady Financials Will Shape Outlook
Analysts have raised their price target for UPL from $736.09 to $756.34. They cite modest improvements in profit margin and revenue growth forecasts as the reason for this adjustment.
Neues Narrativ • Dec 10
Biosolutions Innovation And Improved Financial Stability Expected To Boost Earnings Growth
Strategic inventory management and sales mix enhancement are expected to boost margins and improve earnings.Aktionärsrenditen
| 512070 | IN Chemicals | IN Markt | |
|---|---|---|---|
| 7D | -2.4% | 0.3% | 0.6% |
| 1Y | -7.9% | -2.3% | -0.2% |
Rendite im Vergleich zur Industrie: 512070 unter dem Niveau der Branche Indian Chemicals , die im vergangenen Jahr eine Rendite von -2.3% erzielte.
Rendite vs. Markt: 512070 hinter dem Markt Indian zurück, der im vergangenen Jahr eine Rendite von -0.2 erzielte.
Preisvolatilität
| 512070 volatility | |
|---|---|
| 512070 Average Weekly Movement | 4.5% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.5% |
Stabiler Aktienkurs: 512070 hatte in den letzten 3 Monaten im Vergleich zum Indian -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: 512070Die wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1969 | 12,000 | Jai Shroff | www.upl-ltd.com |
UPL Limited bietet zusammen mit seinen Tochtergesellschaften Produkte und Lösungen für eine nachhaltige Landwirtschaft in Indien, Europa, Nordamerika, Lateinamerika und international an. Das Unternehmen ist in drei Segmenten tätig: Pflanzenschutz, Saatgutgeschäft und Non-Agro. Das Segment Crop Protection bietet Herbizide, Fungizide, Insektizide, Akarizide, Saatgutbehandlungsmittel, Adjuvantien, Biolösungen, Produkte für die öffentliche Gesundheit, Begasungsmittel und Nacherntelösungen sowie ProNutiva, eine Lösung für den Pflanzenschutz.
UPL Limited's Grundlagenzusammenfassung
| 512070 grundlegende Statistiken | |
|---|---|
| Marktanteil | ₹503.83b |
| Gewinn(TTM) | ₹19.22b |
| Umsatz(TTM) | ₹518.39b |
26.3x
Kurs-Gewinn-Verhältnis 1.0x
Kurs-Umsatz-VerhältnisIst 512070 zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| 512070 Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | ₹518.39b |
| Kosten der Einnahmen | ₹258.91b |
| Bruttogewinn | ₹259.48b |
| Sonstige Ausgaben | ₹240.26b |
| Gewinn | ₹19.22b |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 22.76 |
| Bruttomarge | 50.06% |
| Nettogewinnspanne | 3.71% |
| Schulden/Eigenkapital-Verhältnis | 53.4% |
Wie hat sich 512070 auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
1.0%
Aktuelle Dividendenrendite27%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/24 01:05 |
| Aktienkurs zum Tagesende | 2026/06/24 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2026/03/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
UPL Limited wird von 40 Analysten beobachtet. 16 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |